1. People of the State of New York vs GlaxoSmithKline. Filed June 2, 2004.
2. Curfman GD, Morrissey S, Drazen JM. Expression of concern: Bombardier et al., Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med. 2000;343:1520–8. N Engl J Med 2005;353(26):2813–4.
3. DeAngelis CD, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the international committee of medical journal editors. JAMA. 2004;292(11):1363–4.
4. AdvaMed Response to the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) Request for Comments on Delayed Disclosure. March 31, 2006.
5. Popp RL, Lorell BH, Stone GW, Laskey W, Smith JJ, Kaplan AV. An outline for public registration of clinical trials evaluating medical devices. J Am Coll Cardiol. 2006;47(8):1518–21.